These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3666127)

  • 21. CC-1065 (NSC 298223), a potent new antitumor agent improved production and isolation, characterization and antitumor activity.
    Martin DG; Biles C; Gerpheide SA; Hanka LJ; Krueger WC; McGovren JP; Mizsak SA; Neil GL; Stewart JC; Visser J
    J Antibiot (Tokyo); 1981 Sep; 34(9):1119-25. PubMed ID: 7328053
    [No Abstract]   [Full Text] [Related]  

  • 22. [N1-substituted 1H-indazole-3-ethyl carboxylates and 1H-indazole-3-hydroxamic acids].
    Bistocchi GA; De Meo G; Pedini M; Ricci A; Brouilhet H; Boucherie S; Rabaud M; Jacquignon P
    Farmaco Sci; 1981 May; 36(5):315-33. PubMed ID: 7238851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Azoles. 18. Sulfonylindazole derivatives].
    Dudzińska-Usarewicz J; Wrzeciono U; Frankiewicz A; Linkowska E; Köhler T; Nuhn P
    Pharmazie; 1988 Sep; 43(9):611-3. PubMed ID: 3149748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Derivatives of 4,5,6,7-tetrahydro-7,8,8-trimethyl-3-phenylamino-4,7-methano-2H-ind azo le with hypotensive and hypoglycemic activities. II.
    Ranise A; Bondavalli F; Schenone P; Lampa E; Greco R; Scafuro M; Marmo E
    Farmaco Sci; 1984 Mar; 39(3):200-7. PubMed ID: 6714414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Synthesis of the antitumor antibiotic CC-1065 by a Streptomyces canulus 106/78 culture].
    Ivanitskaia LP; Taĭg MM; Frolova VI; Kuzovkov AD
    Antibiotiki; 1982 May; 27(5):323-6. PubMed ID: 7103439
    [No Abstract]   [Full Text] [Related]  

  • 26. Binding of CC-1065 to poly- and oligonucleotides.
    Krueger WC; Li LH; Moscowitz A; Prairie MD; Petzold G; Swenson DH
    Biopolymers; 1985 Aug; 24(8):1549-72. PubMed ID: 4041550
    [No Abstract]   [Full Text] [Related]  

  • 27. A novel series of selective leukotriene antagonists: exploration and optimization of the acidic region in 1,6-disubstituted indoles and indazoles.
    Yee YK; Bernstein PR; Adams EJ; Brown FJ; Cronk LA; Hebbel KC; Vacek EP; Krell RD; Snyder DW
    J Med Chem; 1990 Sep; 33(9):2437-51. PubMed ID: 2391686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Azoles. Part 5: On halogen-nitroindazole derivatives and their antibacterial properties (author's transl)].
    Wrzeciono U; Pietkiewicz K; Niewegłowska W; Michalska W
    Pharmazie; 1979 Jan; 34(1):20-2. PubMed ID: 432251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Synthesis and pharmacological activity of 2,3-dihydro-1H-pyrazolo-[1,2-a]indazolium derivatives].
    Fujimura Y; Shiraki Y; Nawata Y; Matsunaga I
    Yakugaku Zasshi; 1986 Nov; 106(11):1002-7. PubMed ID: 3559900
    [No Abstract]   [Full Text] [Related]  

  • 30. Potential antitumor agents, XIII. Indole derivatives related to lonidamine.
    Andreani A; Rambaldi M; Bonazzi D; Andreani F; Bossa R; Galatulas I
    Arch Pharm (Weinheim); 1984 Oct; 317(10):847-51. PubMed ID: 6517671
    [No Abstract]   [Full Text] [Related]  

  • 31. Structure of CC-1065 (NSC-298223), a new antitumor antibiotic.
    Martin DG; Chidester CG; Duchamp DJ; Mizsak SA
    J Antibiot (Tokyo); 1980 Aug; 33(8):902-3. PubMed ID: 7429992
    [No Abstract]   [Full Text] [Related]  

  • 32. Synthesis and antitumor activity of CBI-bearing ester and carbamate prodrugs of CC-1065 analogue.
    Wang Y; Li L; Tian Z; Jiang W; Larrick JW
    Bioorg Med Chem; 2006 Dec; 14(23):7854-61. PubMed ID: 16908174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metal cation complexation and activation of reversed CPyI analogues of CC-1065 and duocarmycin SA: partitioning the effects of binding and catalysis.
    Ellis DA; Wolkenberg SE; Boger DL
    J Am Chem Soc; 2001 Sep; 123(38):9299-306. PubMed ID: 11562212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and antiproliferative activity of triazenoindazoles and triazenopyrazoles: a comparative study.
    Daidone G; Raffa D; Maggio B; Valeria Raimondi M; Plescia F; Schillaci D
    Eur J Med Chem; 2004 Mar; 39(3):219-24. PubMed ID: 15051169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The preparation of a 3-alkylindazoles].
    Hannig E; Kollmorgen C; Körner M
    Pharmazie; 1976 Aug; 31(8):534-6. PubMed ID: 996071
    [No Abstract]   [Full Text] [Related]  

  • 36. [Heterocyclic compounds containing the residue of a 4-aminophenylalkanoic acid with potential anti-inflammatory activity. IV. Derivatives of 2-phenyl-2H-indazole].
    Picciòla G; Ravenna F; Carenini G; Gentili P; Riva M
    Farmaco Sci; 1981 Dec; 36(12):1037-56. PubMed ID: 6976273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1,2,9,9a-Tetrahydrocyclopropa[c]benz[e]indol-4-one (CBI) analogs of CC-1065 and the duocarmycins: synthesis and evaluation.
    Boger DL; Yun W; Han N
    Bioorg Med Chem; 1995 Nov; 3(11):1429-53. PubMed ID: 8634824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CC-1065 (NSC 298223), a most potent antitumor agent: kinetics of inhibition of growth, DNA synthesis, and cell survival.
    Bhuyan BK; Newell KA; Crampton SL; Von Hoff DD
    Cancer Res; 1982 Sep; 42(9):3532-7. PubMed ID: 7105029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and preliminary cytotoxicity study of glucuronide derivatives of CC-1065 analogues.
    Wang Y; Yuan H; Wright SC; Wang H; Larrick JW
    Bioorg Med Chem; 2003 Apr; 11(7):1569-75. PubMed ID: 12628680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New N-amino acid derivatives of daunorubicin.
    Dzieduszycka M; Stefanska B; Borowski E; Martelli S
    Farmaco Sci; 1986 Nov; 41(11):881-91. PubMed ID: 3803566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.